Search details
1.
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas.
Blood
; 143(9): 822-832, 2024 Feb 29.
Article
in English
| MEDLINE | ID: mdl-38048694
2.
Non-equivalence of Wnt and R-spondin ligands during Lgr5+ intestinal stem-cell self-renewal.
Nature
; 545(7653): 238-242, 2017 05 11.
Article
in English
| MEDLINE | ID: mdl-28467820
3.
Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study.
Haematologica
; 107(7): 1633-1642, 2022 07 01.
Article
in English
| MEDLINE | ID: mdl-34407602
4.
Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma.
BMC Cancer
; 22(1): 231, 2022 Mar 03.
Article
in English
| MEDLINE | ID: mdl-35236331
5.
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.
Blood
; 133(9): 919-926, 2019 02 28.
Article
in English
| MEDLINE | ID: mdl-30617197
6.
Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencing.
Future Oncol
; 17(31): 4171-4183, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34313135
7.
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study.
Haematologica
; 105(9): 2298-2307, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-33054054
8.
Gene set meta-analysis with Quantitative Set Analysis for Gene Expression (QuSAGE).
PLoS Comput Biol
; 15(4): e1006899, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30939133
9.
Follicular Lymphoma Evaluation Index (FLEX): A new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy.
Am J Hematol
; 95(12): 1503-1510, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32815559
10.
Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing.
J Immunol
; 198(4): 1460-1473, 2017 02 15.
Article
in English
| MEDLINE | ID: mdl-28087666
11.
Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During Pregnancy.
J Immunol
; 198(6): 2479-2488, 2017 03 15.
Article
in English
| MEDLINE | ID: mdl-28179497
12.
Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.
Br J Haematol
; 202(3): 686-689, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37218065
13.
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.
Blood
; 137(19): 2704-2707, 2021 05 13.
Article
in English
| MEDLINE | ID: mdl-33512481
14.
The Repertoire Dissimilarity Index as a method to compare lymphocyte receptor repertoires.
BMC Bioinformatics
; 18(1): 155, 2017 Mar 07.
Article
in English
| MEDLINE | ID: mdl-28264647
15.
Quantitative gene set analysis generalized for repeated measures, confounder adjustment, and continuous covariates.
BMC Bioinformatics
; 16: 272, 2015 Aug 28.
Article
in English
| MEDLINE | ID: mdl-26316107
16.
Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.
Hepatology
; 59(4): 1262-72, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-23929627
17.
Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations.
Nucleic Acids Res
; 41(18): e170, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23921631
18.
NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL.
Leuk Lymphoma
; 65(5): 618-628, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38337191
19.
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma.
bioRxiv
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38328071
20.
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.
Blood Adv
; 6(3): 1025-1037, 2022 02 08.
Article
in English
| MEDLINE | ID: mdl-34941996